AL-06. Influence of allogeneic hematopoietic stem cell transplantation on the treatment outcomes in patients with Ph-positive acute B-lymphoblastic leukaemia

Cellular Therapy and Transplantation

article

Valeriia C. Luchkina¹  Olga A. Aleshina¹  Zalina T. Fidarova¹  Larisa A. Kuzmina¹  Galina A. Isinova¹  Ekaterina S. Kotova¹  Anastasia N. Vasileva¹  Sergey N. Bondarenko¹  Valerii A. Lapin¹  Zalina Kh. Akhmerzaeva¹  Mikhail Y. Drokov¹  Vera V. Troitskaya¹  Elena N. Parovichnikova¹ 

[1] National Medical Research Center for Hematology

关键词: Acute B-lymphoblastic leukaemia;    Ph-positive;    allo-HSCT.;   

DOI  :  10.18620/ctt-1866-8836-2022-11-3-1-132

学科分类：肿瘤学

来源: Universitaetsklinikum Hamburg - Eppendorf / University Medical Center Hamburg - Eppendorf

【 摘 要 】

Hematopoietic stem cell transplantation (HSCT) has improved the results of treatment in patients with hematological malignancies. This option is included in Russian treating protocols of acute B-lymphoblastic leukaemia (B-ALL) from very high-risk group, in particular for Ph-positive variant. The aim of our work was to determine an importance of HSCT after the achieving of CR1 in adult patients with Ph-positive acute B-lymphoblastic leukaemia, to determine risk factors during an execution of program therapy.

【 授权许可】

CC BY